OTCQX:ZEST - NYSE:STNG - OTCQB:PGTK - OTCQB:PMCB - OTCQB:WTER - OTCQX:AVMXY - 24/7 Market News

Venture Breakfast Bits, by 24/7 Market News

2018-12-04T10:03:23+00:00 Dec. 4, 2018 9:59AM EST|

Venture Market News for December 4, 2018

  • AVITA Medical Announces Institutional Placement of A$40.0 Million to Support Commercialization and Pipeline Advancement

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced an institutional placement of A$40.0 million (Institutional Placement) to fund the marketing and sales effort to support U.S. market launch of the RECELL® System, clinical and research and development to facilitate pipeline advancement, and general working capital requirements.

Full press release

  • Pacific Green Executes Agreements Totalling an Estimated $79.6m to Supply Its Envi-Marine System for 52 Vessels Owned or Managed by Scorpio Tankers Inc. and Has Granted Options to Supply Up to a Further 28 Vessels

SAN JOSE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Pacific Green Technologies Inc. (PGTK) (OTCQB: PGTK), owner of the ENVI-MarineTM Exhaust Gas Scrubbing System (System), is pleased to announce that its wholly owned subsidiary, Pacific Green Marine Technologies Inc. (PGMT), has executed an agreement to manufacture its System for 52 vessels owned or managed by SCORPIO TANKERS INC. (NYSE: STNG) (Agreements).

Full press release

  • PharmaCyte Biotech Engages cGMP Validation to Assist in Preparation of IND for Pancreatic Cancer Trial

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has engaged cGMP Validation L.L.C. (cGMP Validation) to assist in the preparation of the Investigational New Drug application (IND) that must be submitted to and approved by the U.S. Food and Drug Administration (FDA) before PharmaCyte can begin its planned clinical trial in patients with locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC).

Full press release

  • Alkaline Water Co Approved to Trade on NASDAQ Stock Market

Trading to Commence on December 10, 2018

SCOTTSDALE, Ariz., Dec. 04, 2018 (GLOBE NEWSWIRE) -- The Alkaline Water Company Inc. (OTCQB and TSXV: WTER), with products bottled under the trademark Alkaline88®, today announced that its shares of common stock have been approved for listing on The NASDAQ Capital Market (NASDAQ).

Full press release

  • Ocean Mist Farms Selects Zest Fresh to Optimize Freshness Management

SAN JOSE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Zest Labs, an AgTech company modernizing the post-harvest fresh food supply chain, today announced that Ocean Mist Farms, supplier of a full line of premium, fresh vegetables from multiple growing regions throughout California, Arizona and Mexico, is utilizing Zest Fresh™ to automate data collection on the condition of its produce and improve process visibility and operational efficiency from the field to the packing house. Zest Fresh helps ensure produce is consistently delivered with maximum freshness and quality. Zest Labs is a wholly-owned subsidiary of Ecoark Holdings, Inc. (OTCQX: ZEST).

Full press release

Connect with 24/7 Market News on social media

https://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com 

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements

CONTACT:

24/7 Market News

Editor@247marketnews.comTop of Form

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/